NPM1 mutations may be associated with adverse outcome in the setting of myeloid neoplasms with complex karyotype

Maximiliano Ramia de Cap, Leo P. Wu, German A. Pihan, Damodaran Narayanan, Elizabeth A. Morgan, Geraldine S. Pinkus, Paola Dal Cin, Stephanie N. Hurwitz, Adam Bagg, Sanjay S. Patel, Wayne Tam, Madhu M. Ouseph, Jeffrey Gagan, Yazan F. Madanat, Alexa Siddon, Philipp W. Raess, Heesun J. Rogers, Carlos E. Bueso-Ramos, Rashmi Kanagal-Shamanna, Jason H. KurzerDaniel A. Arber, Robert P. Hasserjian, Olga K. Weinberg

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Article number106965
JournalLeukemia Research
Volume123
DOIs
StatePublished - Dec 2022

Keywords

  • AML
  • Cancer
  • Genetics
  • Leukemia
  • Myeloid Sarcoma
  • NPM1
  • Oncology
  • Pathology

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this